Doi.org/10.1093/annonc/mdr479

Target Article

Retraction: Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/ cisplatin in patients with locally advanced and metastatic bladder cancer (DOI:10.1093/annonc/mdj965); J. T. Roberts, H. von der Maase, L. Sengeløv, P. F. Conte, L. Dogliotti, T. Oliver, M. J. Moore, A. ; NULL; 2011-11-1; https://doi.org/10.1093/annonc/mdr479

Reasons

Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.